|
|
| NDC Number | Brand Name | Generic Name | Labeler | Dosage Form | DEA Schedule | Marketing Start Date |
|---|---|---|---|---|---|---|
| 55292-820 | Enjaymo | sutimlimab-jome | Recordati Rare Diseases, Inc. | INJECTION, SOLUTION, CONCENTRATE | 2022-02-04 | |
| 80203-347 | Enjaymo | sutimlimab-jome | Bioverativ Therapeutics Inc. | INJECTION, SOLUTION, CONCENTRATE | 2022-02-04 |
Loading full table content...